In conclusion it would be regrettable if readers would hypertension continue to be overlooked ? Semin Dial 1997;  conclude from reports such as Salem's [6 ] that lowering 10: 250 elevated blood pressure is unnecessary and harmful. 5. Flanigan MJ. Dialysis and hypertension: worthy of investi-Fortunately, the authors do not draw that conclusion. gation? Semin Dial 1998; 11: 109-112 But decisions like that of the HCFA are a sign on the 6. Salem MM. Hypertension in the hemodialysis population: any relation to two years survival ? Nephrol Dial Transplant. 1998; ? wall. Let all of us beware, the secret of real improve- For 20 years, disparity between dialysis survival in take as a 'given' that the country that invented main-Europe and the US has been a vexing concern. tenance haemodialysis, continuous ambulatory peri-Especially difficult to understand is the nearly miracutoneal dialysis and kidney transplantation is incapable lous longevity reported in Tassin, France by Laurent, of delivering treatment at a standard uniformly prac-Calemard and Charra [1] . In a stirring 1983 retrospectticed in less-rich nations. The reality that European ive analysis of 373 haemodialysis patients, survival was treatment rates are half that in the US, meaning that 75% at 10 years and 65% at 15 years [1] . Setting aside sicker and older patients, those most likely to die, are a potentially key criticism, the authors classified their grossly excluded, was ignored. Instead, the 'American patients as 'an unselected population.' However, only Tragedy' was explained by defective dialysis, due to 15 (4%) of the Tassin subjects had diabetes while dialyser reuse or inordinately short dialysis treatment another 15 (4%) had systemic disease. What happened times. Worry over application of American 'short to uraemic diabetic people in Tassin who were not dialysis' spread to Europe [3] . Troubled by substandaccepted for dialytic therapy? They died, uncounted in ard quality in dialysis care, the National Kidney any survival statistics.
Foundation, supported by an 'unrestricted educational Previously, I rebutted the assertion that the Tassin grant' from AMGEN Inc., Thousand Oak, CA, USA, dialysis subset was representative of the renal-failure conducted a broad extensive review termed the Dialysis population at large on the grounds that the low Outcomes Quality Initiative (DOQI ) [4] . Virtually prevalence of co-morbidity, especially diabetes, must every aspect of the dialysis process from the establishbe the result of strict selection. It follows, I deduced, ment of a vascular access to management of anaemia that the purportedly distinctly superior survival was a and metabolic bone disease is spelled out in DOQI misperception: the product of comparing nonequivaadvisories. Not covered, however, is the patient referral lent cohorts in France and the US [2] .
process that may exclude elderly, diabetic and minority Apologists for the American style of uraemia therapy group members.
Elsewhere in this issue, Chantrel et al.1 lament the high mortality in type II diabetic haemodialysis by exclusion of the first 90 days by the US Renal Data carefully performed dialytic therapy is a desirable objective for all clinical nephrologists striving for excel-System [5] . Nevertheless, it is evident that Chantrel lence in patient care. Improving the outcome of dialysis et al. had to cope with extensive undertreatment of in diabetic patients is a complex and elusive goal hypertension as well as absent planning for the proviworthy of all of us. Chantrel et al. are to be congratusion of a vascular access and elective initiation of lated for their candor in recounting the complexity, uremia therapy. Had this cohort of diabetic patients stress and disappointment that is usual when trying to been intermixed with the Tassin selectees, the slope of deliver uraemia therapy to diabetic patients afflicted survival curves would have been bent downward. In with life-threatening extrarenal co-morbidity. other words, the best method for ensuring superior survival is to treat patients less likely to die. acidosis is restricted to type I diabetes when it is Adv Nephrol Necker Hosp 1989; 18: 273-296 actually more prevalent in type II diabetes [6, 7] .
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(iv) Ophthalmoscopy is inadequate screening for the DOQI. National Kidney Foundation, Inc., New York, 1997 detection of diabetic retinopathy missing 25% of cases 
